Ironwood Pharmaceuticals (IRWD) Change in Accured Expenses (2010 - 2026)

Ironwood Pharmaceuticals has reported Change in Accured Expenses for 17 years, with the latest figure at -$219000.0 in Q1 2026.

• Quarterly Change in Accured Expenses fell 217.11% year-over-year to -$219000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 116.79% YoY) and the FY2025 annual result came in at $4.0 million, up 119.62% from the prior year.
• Change in Accured Expenses grew to -$219000.0 in Q1 2026 per IRWD's latest filing, from -$2.6 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $16.9 million in Q4 2022 and troughed at -$15.7 million in Q2 2024.
• A 5-year average of -$301882.4 and a median of -$219000.0 in 2026 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses sank 5251.13% in 2022, then soared 15397.1% in 2025.
• Over 5 years, Change in Accured Expenses stood at $16.9 million in 2022, then sank by 117.75% to -$3.0 million in 2023, then sank by 91.35% to -$5.8 million in 2024, then surged by 55.58% to -$2.6 million in 2025, then surged by 91.43% to -$219000.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$219000.0, -$2.6 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.